Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:LMAT) with a Outperform and maintains $92 price target.
- Headlines
- Barrington Research Maintains Outperform on LeMaitre Vascular, Maintains $92 Price Target
Barrington Research Maintains Outperform on LeMaitre Vascular, Maintains $92 Price Target
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
18:47
India will hold a launch activity for the space docking test on December 30 (next Monday).
18:42
Russian President Putin signed a law on withdrawing from the Multilateral Nuclear Environmental Program Agreement (MNEPR).
18:29
USA National Highway Traffic Safety Administration: Kia USA announced the recall of 22,883 Autos sold in the USA.